AU1960488A – Cysteine proteinase inhibitor
– Google Patents
AU1960488A – Cysteine proteinase inhibitor
– Google Patents
Cysteine proteinase inhibitor
Info
Publication number
AU1960488A
AU1960488A
AU19604/88A
AU1960488A
AU1960488A
AU 1960488 A
AU1960488 A
AU 1960488A
AU 19604/88 A
AU19604/88 A
AU 19604/88A
AU 1960488 A
AU1960488 A
AU 1960488A
AU 1960488 A
AU1960488 A
AU 1960488A
Authority
AU
Australia
Prior art keywords
proteinase inhibitor
cysteine proteinase
cysteine
inhibitor
proteinase
Prior art date
1987-06-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU19604/88A
Other versions
AU604944B2
(en
Inventor
Magnus Abrahamson
Anders Grubb
Jerzy Trojnar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1987-06-18
Filing date
1988-06-17
Publication date
1989-01-19
1988-06-17
Application filed by Individual
filed
Critical
Individual
1989-01-19
Publication of AU1960488A
publication
Critical
patent/AU1960488A/en
1991-01-03
Application granted
granted
Critical
1991-01-03
Publication of AU604944B2
publication
Critical
patent/AU604944B2/en
2008-06-17
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
C07K5/08—Tripeptides
C07K5/0802—Tripeptides with the first amino acid being neutral
C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/04—Antibacterial agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/12—Antivirals
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P35/00—Antineoplastic agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P7/00—Drugs for disorders of the blood or the extracellular fluid
A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
Y02P20/00—Technologies relating to chemical industry
Y02P20/50—Improvements relating to the production of bulk chemicals
Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
AU19604/88A
1987-06-18
1988-06-17
Cysteine proteinase inhibitor
Ceased
AU604944B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
SE8702550A
SE8702550D0
(en)
1987-06-18
1987-06-18
CYSTEINPROTEASHEMMARE
SE8702550
1987-06-18
Publications (2)
Publication Number
Publication Date
AU1960488A
true
AU1960488A
(en)
1989-01-19
AU604944B2
AU604944B2
(en)
1991-01-03
Family
ID=20368906
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU19604/88A
Ceased
AU604944B2
(en)
1987-06-18
1988-06-17
Cysteine proteinase inhibitor
Country Status (7)
Country
Link
US
(1)
US5037957A
(en)
EP
(1)
EP0418233A1
(en)
JP
(1)
JPH02503917A
(en)
AU
(1)
AU604944B2
(en)
FI
(1)
FI896029A0
(en)
SE
(1)
SE8702550D0
(en)
WO
(1)
WO1988010266A1
(en)
Families Citing this family (23)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US5189144A
(en)
*
1989-04-28
1993-02-23
Takara Shuzo Co., Ltd.
Human calpastatin-like polypeptide
US5444042A
(en)
*
1990-12-28
1995-08-22
Cortex Pharmaceuticals
Method of treatment of neurodegeneration with calpain inhibitors
US5472945A
(en)
*
1991-08-13
1995-12-05
Temple University- Of The Commonwealth System Of Higher Education
Modulation of blood pressure and inhibition of platelet activation with kininogen fragment
IL112759A0
(en)
1994-02-25
1995-05-26
Khepri Pharmaceuticals Inc
Novel cysteine protease inhibitors
US5693617A
(en)
*
1994-03-15
1997-12-02
Proscript, Inc.
Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
US6660268B1
(en)
1994-03-18
2003-12-09
The President And Fellows Of Harvard College
Proteasome regulation of NF-KB activity
DE69531103T2
(en)
*
1994-04-19
2004-05-19
Kanebo, Ltd.
PREVENTIVE AGENT FOR CIRCULAR DISEASES
US6083903A
(en)
1994-10-28
2000-07-04
Leukosite, Inc.
Boronic ester and acid compounds, synthesis and uses
US5905076A
(en)
*
1996-04-10
1999-05-18
National Research Council Of Canada
6-substituted amino-4-oxa-1-azabicyclo 3,2,0! heptan-7-one derivatives as cysteine protease inhibitors
AU766219B2
(en)
1998-02-02
2003-10-09
1149336 Ontario Inc.
Method of regulating glucose metabolism, and reagents related thereto
US6514941B1
(en)
1999-12-10
2003-02-04
Campina Melkunie B.V.
Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides
US8410053B2
(en)
2001-11-26
2013-04-02
Trustees Of Tufts College
Methods for treating autoimmune disorders, and reagents related thereto
CN1638790A
(en)
*
2002-01-29
2005-07-13
Wyeth公司
Compositions and methods for modulating connexin hemichannels
CA2504933C
(en)
2002-11-06
2012-10-16
Dana-Farber Cancer Institute, Inc.
Methods and compositions for treating cancer using proteasome inhibitors
JP2009510131A
(en)
2005-10-07
2009-03-12
バイオファルミカ リミテッド
Sumoylation control agent and use thereof
US20090258827A1
(en)
2006-04-07
2009-10-15
Biopharmica Ltd.
Transcription Factor Modulator
US9895449B2
(en)
2010-05-25
2018-02-20
Syndevrx, Inc.
Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
DK2576638T3
(en)
2010-05-25
2021-03-15
Syndevrx Inc
POLYMER CONJUGATED METAP2 INHIBITORS AND THERAPEUTIC PROCEDURES FOR USE
AU2014250983B2
(en)
*
2013-04-10
2019-04-11
Syndevrx, Inc.
MetAP2 inhibitors and methods of treating obesity
MX2018006904A
(en)
2015-12-10
2018-08-24
Syndevrx Inc
Fumagillol derivatives and polymorphs thereof.
CN108700568A
(en)
2016-01-06
2018-10-23
隆扎有限公司
Protein degradation inhibitor for improved production
EP3402529A1
(en)
2016-01-11
2018-11-21
Syndevrx, Inc.
Treatment for tumors driven by metabolic dysfunction
CA3117666A1
(en)
2018-10-26
2020-04-30
Syndevrx, Inc.
Biomarkers of metap2 inhibitors and applications thereof
Family Cites Families (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4100117A
(en)
*
1977-04-21
1978-07-11
Eli Lilly And Company
Somatostatin analogs and intermediates thereto
1987
1987-06-18
SE
SE8702550A
patent/SE8702550D0/en
unknown
1988
1988-06-17
JP
JP63505269A
patent/JPH02503917A/en
active
Pending
1988-06-17
WO
PCT/SE1988/000334
patent/WO1988010266A1/en
not_active
Application Discontinuation
1988-06-17
US
US07/435,463
patent/US5037957A/en
not_active
Expired – Fee Related
1988-06-17
EP
EP88906175A
patent/EP0418233A1/en
not_active
Withdrawn
1988-06-17
AU
AU19604/88A
patent/AU604944B2/en
not_active
Ceased
1989
1989-12-15
FI
FI896029A
patent/FI896029A0/en
not_active
Application Discontinuation
Also Published As
Publication number
Publication date
EP0418233A1
(en)
1991-03-27
FI896029A0
(en)
1989-12-15
SE8702550D0
(en)
1987-06-18
JPH02503917A
(en)
1990-11-15
US5037957A
(en)
1991-08-06
WO1988010266A1
(en)
1988-12-29
AU604944B2
(en)
1991-01-03
Similar Documents
Publication
Publication Date
Title
AU1960488A
(en)
1989-01-19
Cysteine proteinase inhibitor
AU632836B2
(en)
1993-01-14
Novel peptidase inhibitors
AU3566089A
(en)
1989-11-29
Retroviral protease inhibitors
AU1025588A
(en)
1988-07-21
Novel peptidase inhibitors
AU1037588A
(en)
1988-09-01
Renin inhibitors
AU2469388A
(en)
1989-05-11
Renin inhibitors
AU5288186A
(en)
1986-08-07
Novel peptidase inhibitors
AU7168091A
(en)
1991-07-24
Mercaptocycloacyl aminoacid endopeptidase inhibitors
AU9122391A
(en)
1992-06-25
Hiv protease inhibitors
AU581405B2
(en)
1989-02-23
Protease inhibitors
AU2390692A
(en)
1993-03-02
Beta-glucuronidase inhibitor
AU584502B2
(en)
1989-05-25
Phenylalanine derivatives and proteinase inhibitor
AU5069993A
(en)
1994-06-30
Retroviral protease inhibitors
AU6811690A
(en)
1991-03-14
Lipoxygenase inhibitors
AU4678489A
(en)
1990-06-21
Retroviral protease inhibitors
JPS6429365A
(en)
1989-01-31
Dopamine-beta-hydroxylase inhibitor
AU1644788A
(en)
1988-12-01
Dopamine-beta-hydroxylase inhibitors
AU3707989A
(en)
1990-01-04
Angiogenesis inhibitor
AU7132391A
(en)
1991-08-29
Hiv protease inhibitors
AU4721489A
(en)
1990-07-05
Renin inhibitors
AU587691B2
(en)
1989-08-24
Phenylalanine derivative and proteinase inhibitor
AU1003188A
(en)
1988-07-14
Dopamine-beta-hydroxylase inhibitors
AU1370688A
(en)
1988-09-22
Dopamine-beta-hydroxylase inhibitors
AU3735793A
(en)
1993-09-13
Retroviral protease inhibitors
AU6193490A
(en)
1991-03-14
Peptidyl difluorodiol renin inhibitors
None